drugset / Trial / NCT02137616

Antipsychotic to Treat Psychosis Syndrome

NCT02137616

Unknown 300 enrolled Central South University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This study assess the safety and effects of atypical antipsychotics in subjects with psychosis syndrome and psychosis risk syndrome.

Timeline

Start
2012-06
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified
Comparator Olanzapine Small molecule
Comparator Quetiapine Small molecule
Comparator Risperidone Other / unclassified

Indications